Many patients feel anxious when they first hear the words “infusion therapy.” One of the most common misconceptions is that IV treatment for eye disease means cancer chemotherapy. In reality, ophthalmic infusion therapy is very different.
Is Infusion Therapy for Eye Disease Chemotherapy?
No. Infusion therapy used in ophthalmology is not cancer chemotherapy. Instead, these treatments use immunomodulatory medications designed to control severe inflammation and autoimmune activity affecting the eyes.
At the Massachusetts Eye Research and Surgery Institution (MERSI), infusion therapy is commonly used to help patients with complex inflammatory eye diseases that cannot be adequately controlled with eye drops, oral medications, or injections alone.
Why Do Some Eye Diseases Require IV Treatment?
Certain inflammatory eye conditions can threaten vision if inflammation is not controlled quickly and effectively.
Conditions that may require infusion therapy include:
-
- Uveitis
- Scleritis
- Ocular cicatricial pemphigoid
These diseases are often autoimmune-related and may require systemic treatment to prevent permanent vision damage.
How Is Ophthalmic Infusion Therapy Different From Chemotherapy?
Cancer chemotherapy is designed to destroy rapidly growing cancer cells throughout the body. Ophthalmic infusion therapy works differently.
The medications used in ophthalmic infusion suites are intended to:
-
- Reduce damaging inflammation
- Regulate abnormal immune system activity
- Preserve long-term eye health and vision
Treatment is carefully monitored by ophthalmologists and infusion specialists throughout the process.
What Medications Are Commonly Used?
Depending on the patient’s diagnosis and medical history, medications may include:
-
- Solu-Medrol
- Infliximab
- Rituximab
- Tocilizumab
- Teprotumumab
These medications are selected specifically for inflammatory or autoimmune eye disease management.
Safe, Specialized Infusion Therapy for Eye Disease at MERSI
Dedicated ophthalmic infusion suites are uncommon in eye care. MERSI’s integrated infusion suite allows patients to receive specialized ophthalmic evaluation, laboratory monitoring, and IV treatment in one coordinated location.
Patients throughout the Greater Boston area can access advanced infusion therapy at MERSI in Waltham.
FAQs
Is infusion therapy for eye disease cancer treatment?
No. Ophthalmic infusion therapy is used to control inflammation and autoimmune activity affecting the eyes.
Are infusion medications injected into the eye?
No. Medications are administered through an IV placed in the arm.
What eye diseases may require infusion therapy?
Conditions such as uveitis, scleritis, and ocular cicatricial pemphigoid may require IV treatment.